跳至主要内容
临床试验/ITMCTR2200005824
ITMCTR2200005824已完成1 期

Influence of IgA Nephropathy ? Prescription on Serum Gd-IgA1 and BAFF level for Patients with IgA Nephropathy

HuQianqian0 个研究点开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 65(—)
性别
All

入选标准

  • 1. Criteria of Subjects inclusion: (1) According to IgAN western diagnostic criteria and TCM syndrome differentiation criteria; (2) Lee's grade was I-III within 5 years of diagnosis; (3) Aged between 18 and 65; (4) Blood pressure =140/90mmHg; (5) Have not participated in clinical trials of other drugs in the last 3 months; (6) Sign informed consent.
  • 2. Criteria of healthy control group: (1) Patients with infectious diseases, serious underlying diseases, rheumatic immune diseases, mental diseases and history of malignant tumor were excluded; (2) There is no history of IgAN in the family history; (3) Aged between 18 and 65.

排除标准

  • (1) Serum creatinine > 265µmol/L, serum potassium > 5.3mmol/L and 24hUPQ> 3.5g/d; (2) Combined with primary glomerular diseases or secondary glomerular diseases mainly characterized by IgA deposition; (3) Combined with acute and chronic infectious diseases, serious underlying diseases, other rheumatic immune diseases, malignant tumors and mental diseases; (4) Pregnancy, lactation or recent birth plan; (5) Patients with allergic constitution or known allergy to the drugs used in the test; (6) Patients with indications for glucocorticoid treatment or who have used glucocorticoids, immunosuppressants or biological agents in the last 6 months.

研究者

发起方
HuQianqian

相似试验